From the bench · 07 Jan 2026

Sublingual Minoxidil for Hairloss

By Nick Buete

Sublingual Minoxidil for Alopecia: Exploring an Alternative Route of Administration

Alopecia (hair loss) affects many Australians and can significantly impact quality of life. While topical minoxidil remains a common first-line option, some patients are prescribed systemic minoxidil when topical therapy is ineffective or poorly tolerated.

In recent years, interest has grown in sublingual (SL) minoxidil as an alternative to traditional oral tablets. As compounding pharmacists, we are often asked how sublingual minoxidil differs from oral minoxidil, particularly in terms of absorption and bioavailability.

This article provides an overview of these differences and the role of compounding in supporting individualised therapy.

Minoxidil and its use in alopecia

Minoxidil was originally developed as an oral antihypertensive medicine. Its effect on hair growth was observed incidentally, leading to the development of topical formulations for androgenetic alopecia.

In Australia, the use of oral minoxidil for hair loss is off-label and must be prescribed and monitored by a medical practitioner. Its use is typically considered in carefully selected patients.

Routes of administration: oral vs sublingual

Oral minoxidil

Oral minoxidil is swallowed and absorbed through the gastrointestinal tract. After absorption, it undergoes first-pass metabolism in the liver before entering systemic circulation.

Key considerations with oral administration include:

  • Variable absorption influenced by gastrointestinal factors

  • Hepatic first-pass metabolism, which can reduce the amount of active drug reaching systemic circulation

  • Higher systemic exposure at equivalent doses, which may increase the likelihood of dose-related adverse effects in some patients

Despite these considerations, oral minoxidil remains effective and well tolerated for many patients when appropriately prescribed.

Sublingual minoxidil

Sublingual minoxidil is administered under the tongue, allowing absorption through the highly vascular oral mucosa.

This route:

  • Bypasses gastrointestinal absorption

  • Partially avoids first-pass hepatic metabolism

  • May result in greater relative bioavailability at lower doses compared with oral administration

Because the medication enters systemic circulation more directly, some prescribers consider sublingual dosing strategies that are lower than equivalent oral doses. However, it is important to emphasise that sublingual administration does not eliminate systemic exposure.

Bioavailability considerations

Bioavailability refers to the proportion of a drug that reaches systemic circulation in an active form.

With oral minoxidil:

  • A portion of the dose is metabolised before reaching circulation

  • Inter-individual variability can be significant

With sublingual minoxidil:

  • Absorption via the oral mucosa can be more consistent

  • Reduced first-pass metabolism may increase the proportion of active drug available systemically

  • Small dose changes may have a greater clinical effect

Due to these differences, oral and sublingual doses may not be interchangeable on a milligram-for-milligram basis. Prescribers must account for this when initiating or adjusting therapy.

Why compounding is required

Sublingual minoxidil is not commercially available in Australia and must be prepared by a compounding pharmacy following a valid prescription.

Compounding allows for:

  • Individualised dosing aligned with prescriber intent

  • Selection of a suitable sublingual dosage form (such as drops or rapidly dissolving preparations)

  • Exclusion of unnecessary excipients where required

Each compounded medicine is prepared specifically for the individual patient in accordance with Australian compounding standards.

Safety and monitoring

Regardless of the route of administration, minoxidil used systemically requires:

  • Medical supervision

  • Consideration of cardiovascular history and blood pressure

  • Ongoing monitoring for unwanted effects

Patients should follow their prescriber’s instructions closely and discuss any concerns with their healthcare team.

Pharmacists play an important role in supporting safe use by reinforcing correct administration techniques and counselling on what to monitor.

Accessing compounded sublingual minoxidil

If you have been prescribed sublingual minoxidil, our compounding team can prepare your medication in line with your doctor’s instructions.

Prescriptions can be uploaded securely via our website:
👉 https://gardenspharmacy.com.au/compounding/upload

We dispense compounded medicines to patients Australia-wide, with appropriate handling and delivery.

Key points to remember

  • Systemic minoxidil may be prescribed off-label for alopecia in selected patients

  • Sublingual administration offers a different absorption pathway compared with oral tablets

  • Differences in bioavailability mean doses may not be directly interchangeable

  • Compounding enables personalised dosing and alternative dosage forms

  • Prescriber oversight and pharmacist support are essential

This article is intended for general educational purposes only and does not replace personalised medical advice. Always follow the guidance of your prescribing doctor and pharmacist.